Authors:
VAAGE J
DONOVAN D
WIPFF E
ABRA R
COLBERN G
USTER P
WORKING P
Citation: J. Vaage et al., THERAPY OF A XENOGRAFTED HUMAN COLONIC-CARCINOMA USING CISPLATIN OR DOXORUBICIN ENCAPSULATED IN LONG-CIRCULATING PEGYLATED STEALTH LIPOSOMES, International journal of cancer, 80(1), 1999, pp. 134-137
Citation: J. Vaage et al., INHIBITION OF MOUSE MAMMARY-CARCINOMA DEVELOPMENT WITH DOXORUBICIN INLIPOSOMES, International journal of cancer, 75(1), 1998, pp. 158-159
Authors:
HARRINGTON K
ROWLINSONBUSZA G
ABRA R
USTER P
STEWART S
Citation: K. Harrington et al., EFFECT OF TUMOR SIZE ON UPTAKE OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN A TUMOR XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 25-25
Authors:
HARRINGTON K
ROWLINSONBUSZA G
USTER P
STEWART S
Citation: K. Harrington et al., STEALTH LIPOSOME-ENTRAPPED DOXORUBICIN (SLED) AND CISPLATIN (SLEC) VERSUS HEAD AND NECK XENOGRAFT TUMORS, British Journal of Cancer, 78, 1998, pp. 26-26
Authors:
HARRINGTON K
ROWLINSONBUSZA G
USTER P
STEWART S
Citation: K. Harrington et al., STEALTH LIPOSOME-ENCAPSULATED DOXORUBICIN (SLED) AND CISPLATIN (SLEC)FOR TARGETED RADIOSENSITIZATION IN XENOGRAFT TUMORS, British Journal of Cancer, 78, 1998, pp. 27-27
Authors:
HARRINGTON K
ROWLINSONBUSZA G
USTER P
STEWART S
Citation: K. Harrington et al., STEALTH LIPOSOME-ENCAPSULATED IODODEOXYURIDINE (SLIUDR) FOR TARGETED RADIOSENSITIZATION IN XENOGRAFT TUMORS, British Journal of Cancer, 78, 1998, pp. 28-28
Citation: K. Harrington et al., BIODISTRIBUTION AND PHARMACOKINETICS OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) AFTER INTRAPERITONEAL INJECTION IN MICE, British Journal of Cancer, 78, 1998, pp. 29-29
Citation: K. Harrington et al., BIODISTRIBUTION AND PHARMACOKINETICS 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN PATIENTS WITH SOLID CANCERS, British Journal of Cancer, 78, 1998, pp. 29-29
Authors:
HARRINGTON K
ROWLINSONBUSZA G
USTER P
ABRA R
STEWART S
Citation: K. Harrington et al., BIODISTRIBUTION AND PHARMACOKINETICS OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN A HUMAN TUMOR XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 44-44
Authors:
HARRINGTON KJ
ROWLINSONBUSZA G
USTER P
STEWART JSW
Citation: Kj. Harrington et al., STEALTH LIPOSOME-ENTRAPPED DOXORUBICIN (SLED) AND CISPLATIN (SLEC) VERSUS HEAD AND NECK XENOGRAFT TUMORS, European journal of cancer, 33, 1997, pp. 802-802
Citation: J. Vaage et al., TUMOR UPTAKE OF DOXORUBICIN IN POLYETHYLENE GLYCOL-COATED LIPOSOMES AND THERAPEUTIC EFFECT AGAINST A XENOGRAFTED HUMAN PANCREATIC-CARCINOMA, British Journal of Cancer, 75(4), 1997, pp. 482-486
Authors:
ZHU G
OTO E
VAAGE J
QUINN Y
NEWMAN M
ENGBERS C
USTER P
Citation: G. Zhu et al., THE EFFECT OF VINCRISTINE-POLYANION COMPLEXES IN STEALTH LIPOSOMES ONPHARMACOKINETICS, TOXICITY AND ANTI TUMOR-ACTIVITY, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 138-142
Authors:
VAAGE J
DONOVAN D
LOFTUS T
USTER P
WORKING P
Citation: J. Vaage et al., PROPHYLAXIS AND THERAPY OF MOUSE MAMMARY CARCINOMAS WITH DOXORUBICIN AND VINCRISTINE ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES, European journal of cancer, 31A(3), 1995, pp. 367-372
Authors:
VAAGE J
DONOVAN D
MAYHEW E
USTER P
WOODLE M
Citation: J. Vaage et al., THERAPY OF MOUSE MAMMARY CARCINOMAS WITH VINCRISTINE AND DOXORUBICIN ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES, International journal of cancer, 54(6), 1993, pp. 959-964